Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soichiro Shibui

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
Stem Cells (Dayton, Ohio)|July 28, 2011
FoxO3a functions as a key integrator of cellular signals that control glioblastoma stem-like cell differentiation and tumorigenicityJun Sunayama, Atsushi Sato, Ken-Ichiro Matsuda, et al.
Molecular and Clinical Oncology|March 21, 2014
Extended trastuzumab therapy improves the survival of HER2-positive breast cancer patients following surgery and radiotherapy for brain metastasesYoshiko Okita, Yoshitaka Narita, Tsuyoshi Suzuki, et al.
Cancer Nursing|March 18, 2014
Impact of late effects on health-related quality of life in survivors of pediatric brain tumors: motility disturbance of limb(s), seizure, ocular/visual impairment, endocrine abnormality, and higher brain dysfunctionIori Sato, Akiko Higuchi, Takaaki Yanagisawa, et al.
International Journal of Clinical Oncology|May 2, 2018
Employment status and termination among survivors of pediatric brain tumors: a cross-sectional surveyIori Sato, Akiko Higuchi, Takaaki Yanagisawa, et al.
Neuro-Oncology|February 6, 2014
Different spatial distribution between germinal center B and non-germinal center B primary central nervous system lymphoma revealed by magnetic resonance group analysisManabu Kinoshita, Takashi Sasayama, Yoshitaka Narita, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 14, 2006
[Efficacy and safety of monotherapy with temozolomide in patients with anaplastic astrocytoma at first relapse--a phase II clinical study]Ryo Nishikawa, Soichiro Shibui, Motohiko Maruno, et al.
Neuro-Oncology|August 8, 2012
Primary CNS germ cell tumors in Japan and the United States: an analysis of 4 tumor registriesBridget J McCarthy, Soichiro Shibui, Takamasa Kayama, et al.
Acta Neuropathologica|January 24, 2014
Mutually exclusive mutations of KIT and RAS are associated with KIT mRNA expression and chromosomal instability in primary intracranial pure germinomasShintaro Fukushima, Ayaka Otsuka, Tomonari Suzuki, et al.
Cancers|November 26, 2022
Bevacizumab beyond Progression for Newly Diagnosed Glioblastoma (BIOMARK): Phase II Safety, Efficacy and Biomarker StudyMotoo Nagane, Koichi Ichimura, Ritsuko Onuki, et al.
Neuro-Oncology|August 18, 2019
Integrated clinical, histopathological, and molecular data analysis of 190 central nervous system germ cell tumors from the iGCT ConsortiumHirokazu Takami, Kohei Fukuoka, Shintaro Fukushima, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Stem Cells (Dayton, Ohio)|July 28, 2011
FoxO3a functions as a key integrator of cellular signals that control glioblastoma stem-like cell differentiation and tumorigenicityJun Sunayama, Atsushi Sato, Ken-Ichiro Matsuda, et al.
Molecular and Clinical Oncology|March 21, 2014
Extended trastuzumab therapy improves the survival of HER2-positive breast cancer patients following surgery and radiotherapy for brain metastasesYoshiko Okita, Yoshitaka Narita, Tsuyoshi Suzuki, et al.
Cancer Nursing|March 18, 2014
Impact of late effects on health-related quality of life in survivors of pediatric brain tumors: motility disturbance of limb(s), seizure, ocular/visual impairment, endocrine abnormality, and higher brain dysfunctionIori Sato, Akiko Higuchi, Takaaki Yanagisawa, et al.
International Journal of Clinical Oncology|May 2, 2018
Employment status and termination among survivors of pediatric brain tumors: a cross-sectional surveyIori Sato, Akiko Higuchi, Takaaki Yanagisawa, et al.
Neuro-Oncology|February 6, 2014
Different spatial distribution between germinal center B and non-germinal center B primary central nervous system lymphoma revealed by magnetic resonance group analysisManabu Kinoshita, Takashi Sasayama, Yoshitaka Narita, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 14, 2006
[Efficacy and safety of monotherapy with temozolomide in patients with anaplastic astrocytoma at first relapse--a phase II clinical study]Ryo Nishikawa, Soichiro Shibui, Motohiko Maruno, et al.
Neuro-Oncology|August 8, 2012
Primary CNS germ cell tumors in Japan and the United States: an analysis of 4 tumor registriesBridget J McCarthy, Soichiro Shibui, Takamasa Kayama, et al.
Acta Neuropathologica|January 24, 2014
Mutually exclusive mutations of KIT and RAS are associated with KIT mRNA expression and chromosomal instability in primary intracranial pure germinomasShintaro Fukushima, Ayaka Otsuka, Tomonari Suzuki, et al.
Cancers|November 26, 2022
Bevacizumab beyond Progression for Newly Diagnosed Glioblastoma (BIOMARK): Phase II Safety, Efficacy and Biomarker StudyMotoo Nagane, Koichi Ichimura, Ritsuko Onuki, et al.
Neuro-Oncology|August 18, 2019
Integrated clinical, histopathological, and molecular data analysis of 190 central nervous system germ cell tumors from the iGCT ConsortiumHirokazu Takami, Kohei Fukuoka, Shintaro Fukushima, et al.
Pageof 10